Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

QTRX

Quanterix Corp

Sep 15 • 04:00PM ET

4.97

+0.16 3.33 %

Healthcare • Medical Devices • USA • NASD

Peers: ILMN NTRA TWST GH EXAS TMO ABT DHR BIO QGEN

| Held by: VTI IWM VXF IWN VTWO IBB SCHA VHT DFAT FESM

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-1.82	Insider Own	12.86%	Shs Outstand	46.47M	Perf Week	9.96%
Market Cap	230.96M	Forward P/E	-	EPS next Y	-1.25	Insider Trans	9.31%	Shs Float	40.49M	Perf Month	9.47%
Enterprise Value	5.32M	PEG	-	EPS next Q	-0.46	Inst Own	74.76%	Short Float	10.39%	Perf Quarter	-17.99%
Income	-70.50M	P/S	1.84	EPS this Y	-105.62%	Inst Trans	0.03%	Short Ratio	5.73	Perf Half Y	-29.60%
Sales	125.78M	P/B	0.66	EPS next Y	39.13%	ROA	-17.81%	Short Interest	4.21M	Perf YTD	-53.25%
Book/sh	7.52	P/C	0.88	EPS next 5Y	8.08%	ROE	-22.27%	52W High	15.85 -68.65%	Perf Year	-58.82%
Cash/sh	5.62	P/FCF	-	EPS past 3/5Y	14.43% 9.19%	ROIC	-21.84%	52W Low	4.05 22.72%	Perf 3Y	-46.62%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	7.52% 19.36%	Gross Margin	58.53%	Volatility	7.54% 5.80%	Perf 5Y	-83.83%
Dividend TTM	-	EV/Sales	0.04	EPS Y/Y TTM	-96.96%	Oper. Margin	-62.60%	ATR (14)	0.31	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	6.06	Sales Y/Y TTM	-2.74%	Profit Margin	-56.05%	RSI (14)	54.13	Recom	3.00
Dividend Gr. 3/5Y	- -	Current Ratio	6.68	EPS Q/Q	-300.47%	SMA20	6.84%	Beta	1.04	Target Price	6.25
Payout	-	Debt/Eq	0.12	Sales Q/Q	-28.81%	SMA50	-4.76%	Rel Volume	0.64	Prev Close	4.81
Employees	471	LT Debt/Eq	0.10	Earnings	Aug 07 AMC	SMA200	-29.66%	Avg Volume	734.12K	Price	4.97
IPO	Dec 07, 2017	Option/Short	Yes / Yes	EPS/Sales Surpr.	-82.25% -13.29%	Trades		Volume	472,676	Change	3.33%

Date	Action	Analyst	Rating Change	Price Target Change
Aug-11-25	Downgrade	Canaccord Genuity	Buy → Hold	$5
Feb-01-24	Initiated	Scotiabank	Sector Outperform	$30
Sep-25-23	Upgrade	Canaccord Genuity	Hold → Buy	$25 → $32
Aug-08-23	Upgrade	SVB Securities	Market Perform → Outperform	$30
May-23-23	Upgrade	Goldman	Neutral → Buy	$13 → $27
Aug-15-22	Downgrade	Canaccord Genuity	Buy → Hold	$40 → $12
Aug-09-22	Downgrade	SVB Leerink	Outperform → Mkt Perform	$35 → $15
Aug-09-22	Downgrade	Cowen	Outperform → Market Perform	$38 → $18
Mar-02-22	Upgrade	Goldman	Sell → Neutral	$40
Oct-15-21	Resumed	Cowen	Outperform
Jun-04-21	Initiated	Goldman	Sell	$53

Show Previous Ratings

Aug-21-25 04:30PM	Quanterix Accelerator Laboratory Awarded Rigorous New York State Clinical Laboratory Permit (Business Wire)
Aug-12-25 09:35AM	Down 24.3% in 4 Weeks, Here's Why You Should You Buy the Dip in Quanterix (QTRX) (Zacks)
Aug-11-25 07:00AM	Quanterix to Present at the Canaccord Genuity 45th Annual Growth Conference (Business Wire)
Aug-07-25 06:35PM	Quanterix Corporation (QTRX) Reports Q2 Loss, Misses Revenue Estimates (Zacks) -13.79%
04:06PM	Quanterix Releases Financial Results for the Second Quarter of 2025 (Business Wire)
04:02PM	Loading…
Aug-04-25 04:02PM	Quanterix To Report Second Quarter 2025 Financial Results on August 7, 2025 (Business Wire)
09:30AM	Quanterix Announces Cooperation Agreement with Kent Lake Capital (Business Wire)
Jul-28-25 07:00AM	Quanterix Launches Novel p-Tau 205 and p-Tau 212 Assays to Advance Alzheimer's Research at AAIC (Business Wire) +10.94%
Jul-24-25 08:45AM	Exagen (XGN) Soars 5.5%: Is Further Upside Left in the Stock? (Zacks)
Jul-11-25 05:00PM	Quanterix Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (Business Wire)
Jul-08-25 09:07AM	Quanterix Completes Acquisition of Akoya Biosciences, Creating the First Integrated Platform Capable of Measuring Biomarkers Across the Blood and Tissue Continuum (Business Wire)
Jun-23-25 07:30AM	Quanterix Expands Reach with IVD and Large Reference Labs (Business Wire)
Jun-11-25 08:00AM	Kent Lake Condemns Quanterix's Failure to Schedule Its 2025 Annual Meeting as a Tactic to Silence Shareholders (PR Newswire)
Jun-06-25 09:41AM	Quanterix to Present at Goldman Sachs Global Healthcare Conference (Business Wire)
May-23-25 02:21PM	Kent Lake Responds to Quanterix's Post-Effective Amendment and Akoya's Superior $1.40-per-Share Alternative Proposal (PR Newswire)
09:10AM	Loading…
09:10AM	New Data and Deal Flow Signal a Turning Point for Precision-Driven Cancer Biotechs (PR Newswire)
May-13-25 03:09AM	Quanterix Corp (QTRX) Q1 2025 Earnings Call Highlights: Record Consumables Revenue Amidst ... (GuruFocus.com) -19.02%
May-12-25 05:10PM	Quanterix Corporation (QTRX) Reports Q1 Loss, Tops Revenue Estimates (Zacks) +8.52%
04:01PM	Quanterix Releases Financial Results for the First Quarter of 2025 (Business Wire)
May-09-25 09:42AM	Earnings To Watch: Quanterix Corp (QTRX) Reports Q1 2025 Result (GuruFocus.com)
May-07-25 07:40PM	Phibro Animal Health (PAHC) Q3 Earnings Beat Estimates (Zacks)
May-05-25 07:00AM	Quanterix To Report First Quarter 2025 Financial Results on May 12, 2025 (Business Wire)
Apr-30-25 08:00AM	Kent Lake Issues Statement on Quanterix's Blatant Disregard for Will of Shareholders (Business Wire)
Apr-29-25 07:00AM	Quanterix and Akoya Biosciences Announce Amended Merger Agreement (Business Wire)
Apr-17-25 08:30AM	Kent Lake Files Definitive Proxy Statement and Sends Letter to Quanterix Shareholders (Business Wire)
Apr-14-25 08:00AM	Tikvah Management Calls on Quanterix to Explain the Egregious Terms of Convertible Notes Purchased from Akoya Biosciences (Business Wire) +7.69%
Apr-07-25 08:15AM	Kent Lake Comments on Quanterix's Value Destructive Bridge Financing for Financially Troubled Akoya (Business Wire) -12.96%
Apr-02-25 09:41AM	Quanterix: Still Many, Many Questions (Seeking Alpha)
Apr-01-25 01:00AM	Quanterix Showcases Innovation Powered by Simoa at AD/PD with Customer Research and New Dried Blood Spot Extraction Kit (Business Wire)
Mar-24-25 11:03AM	Tikvah Management Announces Intention to Vote AGAINST Quanterix's Proposed Merger with Akoya Biosciences (Business Wire)
04:10PM	Loading…
Mar-19-25 04:10PM	SERA PROGNOSTICS ANNOUNCES APPOINTMENT OF JEFF ELLIOTT TO ITS BOARD; RYAN TRIMBLE AND MARCUS WILSON TO STEP DOWN (PR Newswire)
Mar-18-25 09:18AM	Q4 2024 Quanterix Corp Earnings Call (Thomson Reuters StreetEvents)
03:01AM	Quanterix Corp (QTRX) Q4 2024 Earnings Call Highlights: Strong Revenue Growth Amid Market Challenges (GuruFocus.com)
Mar-17-25 04:01PM	Quanterix Releases Financial Results for the Fourth Quarter of 2024 (Business Wire)
04:00PM	Kent Lake Urges Quanterix Management to Address Key Questions Regarding its Proposed Transaction with Akoya Biosciences During Todays Earnings Call (Business Wire)
04:00PM	Akoya Reports Fourth Quarter of 2024 and Full Year Financial Results (GlobeNewswire)
Mar-13-25 01:00PM	Quanterix To Report Fourth Quarter and Full Year 2024 Financial Results on March 17, 2025 (Business Wire)
Mar-11-25 08:00AM	Kent Lake Issues Investor Presentation Detailing Opposition to Quanterixs Proposed Merger with Akoya Biosciences (Business Wire)
Mar-03-25 08:00AM	Kent Lake Nominates Three Highly Qualified, Independent Candidates for Quanterix Board (Business Wire) -6.59%
06:00AM	Quanterix Highlights Compelling Benefits of Akoya Biosciences Acquisition (Business Wire)
Feb-18-25 03:40PM	Kent Lake Issues Letter to Quanterix Shareholders Regarding Opposition to the Companys Proposed Merger with Akoya Biosciences (Business Wire)
Jan-14-25 07:00AM	Quanterix Provides Update on Financial Performance (Business Wire) -5.93%
Jan-10-25 07:00AM	Quanterix to Acquire Akoya Biosciences, Creating the First Integrated Solution for Ultra-Sensitive Detection of Blood- and Tissue-Based Protein Biomarkers (Business Wire) -19.69%
Jan-06-25 09:30AM	David R. Walt Receives National Medal of Technology and Innovation (Business Wire)
Jan-02-25 04:26PM	Quanterix to Present at the 43rd Annual J.P. Morgan Healthcare Conference (Business Wire) +12.27%
Dec-27-24 04:33AM	Down More Than 60%: Analysts Expect These 2 Beaten-Down Stocks to Rebound in 2025 (TipRanks)
Dec-17-24 06:59AM	Quanterix Expands Capabilities with Strategic Acquisition of EMISSION (Business Wire)
Nov-22-24 05:00PM	Quanterix Announces Receipt of Expected Notice from Nasdaq (Business Wire) +5.70%
07:54AM	Wolf Haldenstein Adler Freeman and Herz LLP announces that it is investigating Quanterix Corporation for potential violations of securities laws (GlobeNewswire)
Nov-21-24 07:00AM	Wolf Haldenstein Adler Freeman and Herz LLP announces that it is investigating Quanterix Corporation for potential violations of securities laws (PR Newswire) +6.35%
Nov-13-24 02:18AM	Quanterix Corp (QTRX) Q3 2024 Earnings Call Highlights: Strong Revenue Growth Amid Instrument ... (GuruFocus.com) -18.26%
Nov-12-24 04:01PM	Quanterix Releases Preliminary Financial Results for the Third Quarter of 2024 (Business Wire)
Nov-11-24 07:14AM	Quanterix Corp (QTRX) Q3 2024: Everything You Need To Know Ahead Of Earnings (GuruFocus.com)
Nov-05-24 04:00PM	Quanterix To Report Third Quarter 2024 Financial Results on November 12, 2024 (Business Wire) +5.99%
Oct-28-24 04:30PM	New Multi-Marker Blood Test from Lucent Diagnostics Increases the Number of Patients Receiving Early Alzheimer's Disease Diagnostic Information (Business Wire) +5.02%
Oct-09-24 05:55PM	Quanterix Corp (QTRX) Q2 2024 Earnings Call Highlights: Strong Revenue Growth Amid Regional ... (GuruFocus.com)
Oct-02-24 04:00PM	Quanterix Welcomes Ivana Magovevi-Liebisch, Ph.D., J.D. to Board of Directors (Business Wire)
Sep-30-24 04:00PM	Quanterix Announces Commercialization of p-Tau 217 Test Kit (Business Wire)
Aug-29-24 04:00PM	Quanterix to Participate at the Morgan Stanley 22nd Annual Global Healthcare Conference (Business Wire)
Aug-19-24 04:32PM	Jeffrey Elliott Appointed to Quanterixs Board of Directors (Business Wire) +7.66%
Aug-15-24 07:18PM	Insider Buying: President & CEO Masoud Toloue Acquires Shares of Quanterix Corp (QTRX) (GuruFocus.com) +9.25%
Aug-08-24 05:10PM	Quanterix Corporation (QTRX) Reports Q2 Loss, Tops Revenue Estimates (Zacks) -14.82%
04:00PM	Quanterix Releases Financial Results for the Second Quarter of 2024 (Business Wire)
Aug-06-24 04:00PM	Quanterix Presenting at Canaccord Genuity 44th Annual Growth Conference (Business Wire) -5.26%
Jul-31-24 04:00PM	Quanterix To Report Second Quarter 2024 Financial Results (Business Wire)
Jul-29-24 10:00AM	Analysts Estimate Quanterix Corporation (QTRX) to Report a Decline in Earnings: What to Look Out for (Zacks) -6.62%
08:00AM	Quanterix Presents Data Demonstrating Successful Multi-Marker Approach for Alzheimers Disease Detection that is More Effective than Standalone Plasma p-Tau 217 (Business Wire)
Jun-17-24 04:00PM	Quanterix to Participate at the Scotiabank Healthcare 1x1 Day (Business Wire) +5.48%
Jun-05-24 04:00PM	Quanterix to Present at 45th Annual Goldman Sachs Global Healthcare Conference (Business Wire)
May-22-24 04:00PM	Quanterix to Present at Leerink Partners Healthcare Crossroads Conference 2024 (Business Wire)
May-15-24 09:55AM	Wall Street Analysts Believe Quanterix (QTRX) Could Rally 67.66%: Here's is How to Trade (Zacks) +6.30%
May-09-24 04:45PM	Quanterix Corporation (NASDAQ:QTRX) Q1 2024 Earnings Call Transcript (Insider Monkey)
03:10AM	Quanterix Corp (QTRX) Q1 2024 Earnings Call Transcript Highlights: Robust Revenue Growth and ... (GuruFocus.com)
May-07-24 09:00PM	QTRX Stock Earnings: Quanterix Beats EPS, Beats Revenue for Q1 2024 (InvestorPlace)
05:10PM	Quanterix Corporation (QTRX) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
04:00PM	Quanterix Releases Financial Results for the First Quarter of 2024 (Business Wire)
Apr-29-24 04:00PM	Quanterix To Report First Quarter 2024 Financial Results (Business Wire)
11:13AM	Canaccord Genuity Adjusts Price Target on Quanterix to $25 From $32, Maintains Buy Rating (MT Newswires)
Mar-21-24 05:30PM	Quanterix Outlines Partner Path With Labs to Expedite Building Global Alzheimer's Disease Testing Infrastructure (Business Wire)
Mar-06-24 09:50AM	Quanterix (QTRX) AD Offering Gets FDA's Breakthrough Device Tag (Zacks)
Mar-04-24 09:00AM	Quanterix Granted Breakthrough Device Designation from U.S. FDA for Blood-Based p-Tau 217 Test for Alzheimers Disease (Business Wire)
Mar-03-24 08:16AM	Quanterix Corporation (NASDAQ:QTRX) Q4 2023 Earnings Call Transcript (Insider Monkey)
Mar-01-24 09:26AM	Q4 2023 Quanterix Corp Earnings Call (Thomson Reuters StreetEvents) +12.69%
Feb-29-24 05:10PM	Quanterix Corporation (QTRX) Reports Q4 Loss, Tops Revenue Estimates (Zacks)
04:00PM	Quanterix Releases Operating Results for Fourth Quarter and Full Year 2023 (Business Wire)
Feb-27-24 10:03AM	Quanterix (QTRX) Expands in Alzheimer's Testing With Alliances (Zacks)
06:34AM	Quanterix Corp (QTRX) Aligns Earnings Release with Annual Report Filing, Reaffirms 2023 Guidance (GuruFocus.com)
Feb-26-24 09:00AM	Quanterix Announces First Collaborations with Five Health Networks to Aid the Diagnosis and Clinical Management of Individuals with Alzheimers Disease (Business Wire)
Feb-23-24 04:30PM	Quanterix to Present at Cowens 44th Annual Health Care Conference (Business Wire)
Feb-16-24 04:00PM	Quanterix Fourth Quarter Earnings and Full Year 2023 Financial Results Conference Call (Business Wire)
Dec-12-23 04:00PM	Quanterix to Present at 42nd Annual J.P. Morgan Healthcare Conference (Business Wire) +8.77%
Dec-04-23 12:00PM	Here's Why Quanterix Corporation (QTRX) is a Great Momentum Stock to Buy (Zacks)
Nov-29-23 09:55AM	Does Quanterix Corporation (QTRX) Have the Potential to Rally 33.74% as Wall Street Analysts Expect? (Zacks)
Nov-13-23 04:00PM	Quanterix To Participate at The Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum (Business Wire) +9.47%
09:55AM	Wall Street Analysts See a 54.88% Upside in Quanterix Corporation (QTRX): Can the Stock Really Move This High? (Zacks)
07:00AM	Sotera Health Appoints Karen Flynn to Board of Directors (GlobeNewswire)
Nov-08-23 12:22PM	Quanterix Corporation (NASDAQ:QTRX) Q3 2023 Earnings Call Transcript (Insider Monkey)
Nov-06-23 05:40PM	Quanterix Corp (QTRX) Raises Full-Year Revenue Expectations Following Q3 2023 Results (GuruFocus.com)
05:30PM	7 Stocks to Buy if You Anticipate a Hot November (InvestorPlace)
04:50PM	Quanterix Releases Operating Results for Third Quarter 202 (Business Wire)

Quanterix Corp. engages in the development of ultra-sensitive digital immunoassay platform that advances precision health for life sciences research and diagnostics. Its products and services include Simoa Assay Kits, HD-X analyzer, SR-X Biomarker Detection System, SP-X Imaging and Analysis System, 2470 Arrayer, Simoa Accelerator Laboratory, Uman NF-Light, and Homebrew -Custom Assay Development. The company was founded by Nicholas J. Naclerio and David R. Walt in April 2007 and is headquartered in Billerica, MA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
WALT DAVID R	Director	Jun 13 '25	Buy	6.14	123,990	760,803	1,866,933	Jun 13 04:39 PM
WALT DAVID R	Director	Jun 12 '25	Buy	6.23	36,010	224,166	1,742,943	Jun 13 04:39 PM
Toloue Masoud	President & CEO	Jun 09 '25	Buy	5.42	45,900	248,723	518,922	Jun 10 04:08 PM
WALT DAVID R	Director	Jun 06 '25	Buy	5.43	131,869	716,576	1,628,802	Jun 09 05:44 PM
WALT DAVID R	Director	Jun 09 '25	Buy	5.34	78,131	417,220	1,706,933	Jun 09 05:44 PM
DONNELLY WILLIAM P	Director	Jun 06 '25	Buy	5.44	93,113	506,348	139,094	Jun 09 05:10 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

QTRX

Quanterix Corp

Upgrade your FINVIZ experience